Harms associated with taking nalmefene for substance use and impulse control disorders: A systematic review and meta-analysis of randomised controlled trials.
<h4>Importance</h4>Nalmefene is a newly approved drug for alcohol use disorder, but the risk of harms has not been evaluated from empirical trial evidence.<h4>Objective</h4>To assess the harm of nalmefene administered to individuals diagnosed with substance use or impulse con...
Saved in:
| Main Authors: | Karina Glies Vincents Johansen, Simon Tarp, Arne Astrup, Hans Lund, Anne K Pagsberg, Robin Christensen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0183821 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vitro and In Vivo Evaluations of PLGA Microspheres Containing Nalmefene.
by: Xiangyang Xie, et al.
Published: (2015-01-01) -
Participation in and use of skills development for work ability and expected retirement age: a cross-sectional study among senior workers
by: Karina Glies Vincents Seeberg, et al.
Published: (2025-02-01) -
Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.
by: Clément Palpacuer, et al.
Published: (2015-12-01) -
The control technology of harmful substances impacting the quality of peanut oil: A review
by: Zifu Ni, et al.
Published: (2025-06-01) -
Glycaemic control: Do no harm
by: L. Kelly
Published: (2012-02-01)